Procter & Gamble (NYSE: PG), a global leader in consumer packaged goods, offers a diverse portfolio of well-known brands across beauty, grooming, health care, and home care. The company's highly anticipated quarterly earnings report was scheduled for April 24, 2026, drawing significant attention from Wall Street analysts.
Analysts had projected an earnings per share (EPS) of $1.56 on revenue of $20.53 billion for the quarter. However, Procter & Gamble significantly exceeded these expectations, reporting an actual EPS of $1.63 and revenue of $21.24 billion. This strong financial performance led to Procter & Gamble shares rising 4% in premarket trading, as reported by CNBC.
The company’s net sales increased by 7%, while organic sales, which exclude factors like currency changes, grew by 3%. Notably, sales volume increased by 2%. This marks the first time in a year that Procter & Gamble has achieved positive volume growth, a key indicator of strengthening consumer demand for its products.
From a stock valuation perspective, Procter & Gamble has a trailing Price-to-Earnings (P/E) ratio of 27.70. This ratio suggests that investors are currently paying $27.70 for every dollar of the company's earnings. Additionally, the company's Price-to-Sales (P/S) ratio stands at 3.93, comparing its stock price to its total revenues.
Regarding its financial health, Procter & Gamble maintains a Debt-to-Equity ratio of 0.68. This metric is crucial for assessing a company's financial leverage by comparing its total debt to its total shareholder equity. Furthermore, its current ratio, which measures its ability to meet short-term obligations, is 0.73.
